Philippe Froguel
Centre National de la Recherche Scientifique(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Inserm(FR)Université de Lille(FR)Institut Pasteur de Lille(FR)Churchill Hospital(GB)Hammersmith Hospital(GB)Centre Hospitalier Universitaire de Lille(FR)University of Oxford(GB)Lille’s Cardiology Hospital(FR)Oxford Centre for Diabetes, Endocrinology and Metabolism(GB)Impact(CA)European Genomic Institute for Diabetes(FR)Imperial College London(GB)McMaster University(CA)
Publications by Year
Research Areas
Pancreatic function and diabetes, Genetic Associations and Epidemiology, Diabetes and associated disorders, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism
Most-Cited Works
- → The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity(2001)4,904 cited
- → Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase(2002)4,196 cited
- → Cloning of adiponectin receptors that mediate antidiabetic metabolic effects(2003)3,155 cited
- → A genome-wide association study identifies novel risk loci for type 2 diabetes(2007)2,996 cited
- → A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction(1998)2,364 cited
- → Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps(2018)1,895 cited